Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01272076 · ClinicalTrials.gov registry record
Cirrus HD-OCT Measurement of Area of Increased Light Penetration Under the Retinal Pigment Epithelium (RPE)
A clinical trial of Age-related Macular Degeneration and Geographic Atrophy, sponsored by Carl Zeiss Meditec.
- Completed
- Registry status
- 85
- Enrollment target
- 2
- Study locations
NCT01272076 is a study of Age-related Macular Degeneration and Geographic Atrophy that has completed, run by Carl Zeiss Meditec. The registered enrollment target is 85 participants, below the 1,507-participant average among 74 other Age-related Macular Degeneration trials with a reported enrollment target (94% lower). The trial reports 2 study locations across 2 states.
The verdict
NCT01272076, a study of Age-related Macular Degeneration and Geographic Atrophy, has completed, sponsored by Carl Zeiss Meditec.
- COMPLETED
- Registry status
- 85 participants
- Enrollment target
- 2
- Study locations
Study Summary
The objective of this study is to compare Cirrus HD-OCT automated measurements of the illumination area under the retinal pigment epithelium (RPE) to expert manual measurements of areas of hypofluorescence typical of geographic atrophy in fundus autofluorescence (FAF) images.
Conditions Studied
Study Locations (2)
California
- East Bay Retina Consultants, Inc. - Oakland
Michigan
- TLC Eyecare and Laser Centers - Jackson
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 85 participants |
| Start Date | 2011-01 |
| Est. Completion | 2011-02 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01272076
The ClinicalTrials.gov registry entry for NCT01272076 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 85 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,507-participant average among 74 other Age-related Macular Degeneration trials with a reported enrollment target (94% lower). The listed sponsor is Carl Zeiss Meditec, which has 18 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Age-related Macular Degeneration appearing as the primary indexed condition, and to 0 interventions.
NCT01272076 reports 2 study locations spanning 2 distinct geographic areas - top geographies include California, Michigan.
Frequently Asked Questions
What is clinical trial NCT01272076 about?
NCT01272076 is a clinical study titled "Cirrus HD-OCT Measurement of Area of Increased Light Penetration Under the Retinal Pigment Epithelium (RPE)". The objective of this study is to compare Cirrus HD-OCT automated measurements of the illumination area under the retinal pigment epithelium (RPE) to expert manual measurements of areas of hypofluorescence typical of geographic atrophy in fundus autofluorescence (FAF) images.
What is the current status of trial NCT01272076?
This trial is currently completed. The enrollment target is 85 participants. The study started on 2011-01. Estimated completion is 2011-02.
What conditions does trial NCT01272076 study?
This clinical trial studies the following conditions: Age-related Macular Degeneration, Geographic Atrophy.
Who is sponsoring clinical trial NCT01272076?
This trial is sponsored by Carl Zeiss Meditec, which has 18 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01272076 being conducted?
This trial has 2 study locations across California, Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Age-related Macular Degeneration
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Dark Adaptation as an Early Indicator of Response to Statin Therapy for Intermediate AMD
RECRUITING · Phase 2
-
Village-Integrated Eye Worker Trial II
RECRUITING · NA
-
High Resolution Retinal Imaging
RECRUITING
-
Visual Remapping to Aid Reading With Field Loss
RECRUITING · NA
-
A Study to Investigate Safety, Tolerability, Pharmacokinetics (PK), Pharmacodynamics (PD), and Immunogenicity of RO7669330 in Participants With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)
RECRUITING · Phase 1
-
Effects of Goji vs. Fiber on Macular Degeneration
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.